InDepth information sheet downloaded from - http://www.bioportfolio.

com on Sunday, March 28, 2010

Pericoronitis
View the current Pericoronitis InDepth page on BioPortfolio.com ( PDF)
(http://www.bioportfolio.com/indepth/Pericoronitis.html) - Regularly Updated.
Pericoronitis is a common problem in young adults with partial tooth impactions. It occurs when the wisdom
tooth has failed to erupt completely through the gum bed, allowing bacteria into an open space around the
tooth, causing infection. What Are the Symptoms of Pericoronitis?1. Pain 2. Infection 3. Swelling in the gum
tissue 4. A "bad taste" in the mouth 5. Swelling of the lymph nodes in the neck 6. Difficulty opening the mouth
Treatment is usually provision of antibiotics to control the infection. In cases where pericoronitis has recurred,
with two or more episodes in the last year, removal of the impacted tooth is indicated.Pericoronitis that
causes symptoms should be treated as soon as possible. If it is not, the infection can spread to other areas of
the mouth. The most severe cases are treated in a hospital and may require intravenous antibiotics and
surgery.nl:Pericoronitis Pericytes ( From the Wikpedia article Pericoronitis.)
Recent Publications on Pericoronitis:


Wisdom teeth: mankind's future third vice-teeth?
The third molar teeth (wisdom teeth) represent the last eruption of the...17th March, 2010
School of Stomatology, Tongji University, Shanghai 200072, China.- Med Hypotheses. 2010
Jan;74(1):52-5. Epub 2009 Sep 17. (DOI Direct Link)
Radiographic quantification of chronic dental infection and its relationship to the atherosclerotic process
in the carotid arteries.
BACKGROUND: Atherosclerosis may be initiated/accelerated by chronic dental...26th January, 2010
Associate Chief of Staff and Director, Graduate Medical Education, VA- Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 2010 Jan 21. (DOI Direct Link)
Assessment of the associated symptoms, pathologies, positions and angulations of bilateral occurring
mandibular third molars: is there any similarity?
OBJECTIVE: The aim of this study was to evaluate and establish any...16th December, 2009
Department of Oral Diagnosis and Radiology, Gazi University School of- Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 2009 Sep;108(3):e26-32. (DOI Direct Link)
Pericoronitis: treatment and a clinical dilemma.
Pericoronitis is an infection associated with impacted lower third molars...17th November, 2009
Dublin Dental Hospital, Dublin.- J Ir Dent Assoc. 2009 Aug-Sep;55(4):190-2.
Importance of radiographs.
Although radiolucency has been shown as a risk of infection, the poorly...30th October, 2009
- Br Dent J. 2009 Aug 8;207(3):96. (DOI Direct Link)
Effect of Mercurius solubilis on the bacteriological response in the alveolitis process in rats.
OBJECTIVE: The purpose of this study was to assess the bacteriological...16th October, 2009
Federal University of Pernambuco, Microbiology Division, Laboratory of- Homeopathy. 2009
Jul;98(3):160-4. (DOI Direct Link)
1/4
Interagency working.
To minimize the risk of intraoperative complications, a comprehensive...16th September, 2009
- Br Dent J. 2009 Jun 13;206(11):562; author reply 562-3. (DOI Direct Link)
Acute inflammation in horizontal incompletely impacted third molar with radiolucency in the elderly.
Although radiolucency has been shown as a risk of infection, the poorly...22nd August, 2009
Matsumoto Dental University, Oral and Maxillofacial surgery, shiojiri,- Clin Interv Aging. 2009;4:337-42.
Epub 2009 Aug 3.
Delayed paresthesia of inferior alveolar nerve after extraction of mandibular third molar: case report and
possible etiology.
OBJECTIVE: The purpose of this study was to assess the bacteriological...21st August, 2009
Department of Oral and Maxillofacial Surgery, University of the Pacific- J Oral Maxillofac Surg. 2009
Aug;67(8):1764-6. (DOI Direct Link)
Angulation of mandibular third molars as a predictive factor for pericoronitis.
AIM: The aims of this study were to investigate the association between...6th August, 2009
Department of Oral Medicine and Oral Surgery, Faculty of Dentistry,- J Contemp Dent Pract. 2009 May
1;10(3):51-8.
[Interradicular course of the inferior alveolar nerve at the mandibular right third molar and monostotic
fibrous dysplasia affecting the mandibular left third molar in the same patient. A case report]
To minimize the risk of intraoperative complications, a comprehensive...21st July, 2009
Klinik fur Oralchirurgie und Stomatologie, Zahnmedizinische Kliniken der- Schweiz Monatsschr
Zahnmed. 2009;119(5):489-502.
Evidenced-based decision making: the third molar.
The American Association of Oral and Maxillofacial Surgeons (AAOMS) has...6th June, 2009
University of Kentucky College of Dentistry, D-136, 800 Rose Street, Room,- Dent Clin North Am. 2009
Jan;53(1):77-96, ix. (DOI Direct Link)
Case report of self-injurious behaviour (SIB) presenting as gingivitis artefacta major.
The case report described here discusses gingivitis artefacta major, an...12th May, 2009
Restorative Dentistry, 4th floor Edinburgh Dental Institute, Edinburgh.- Br Dent J. 2009 Feb
14;206(3):129-31. (DOI Direct Link)
Clinical applications of dental lasers.
Dental lasers currently have 24 clinical indications for use that are...1st April, 2009
University of Maryland Dental School, Baltimore, USA.- Gen Dent. 2009 Jan-Feb;57(1):47-59.
Comparison of periodontal inflammatory disease in young adults with and without pericoronitis involving
mandibular third molars.
PURPOSE: To compare the prevalence and severity of periodontal...14th January, 2009
School of Dentistry, University of North Carolina, Chapel Hill, NC- J Oral Maxillofac Surg. 2009
Jan;67(1):134-9. (DOI Direct Link)
Pericoronitis Patents:

5002769- Compositions for the sustained-release of chlorhexidine
6194434- Cycloalkylaminomethylpyrrolidine derivatives
6309669- Therapeutic treatment and prevention of infections with a bioactive materials encapsulated
within a biodegradable-biocompatible polymeric matrix
2/4
6384050- Tricyclic amine derivatives
6391889- Cis-substituted aminocyclopropane derivatives
6410056- Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a
biodegradable polymeric matrix
6448266- Substituted cyclobutylamine derivatives
6462040- Cis-substituted aminocyclopropane derivative
6462070- Photosensitizer conjugates for pathogen targeting
6191129- Bicyclic amine derivative
6184388- Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted
aminocycloalkylpyrrolidine derivatives
6146655- Flexible intra-oral bandage and drug delivery system
5023082- Sustained-release pharmaceutical compositions
5463053- Optically active pyridobenzoxazine derivatives
5587386- Optically active pyridonecarboxylic acid derivatives
5654318- Bicyclic amine derivatives
5696132- Pyridonecarboxylic acid derivatives
5767127- Optically active pyridonecarboxylic acid derivatives
6031102- Optically active pyridonecarboxylic acid derivatives
6121285- Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted
aminocycloalkylpyrrolidine derivatives
6488912- Treatment of dentoalveolar infections with taurolidine and/or taurultam
6503539- Matrix protein compositions for wound healing
7231122- Photonic crystal waveguides and systems using such waveguides
7232667- Keratinocyte growth factor-2 polynucleotides
7268155- Photosensitizer conjugates for pathogen targeting
7294352- Matrix protein composition for treating inflammation
7310466- Photonic crystal waveguides and systems using such waveguides
7331954- Photonic crystal fibers and medical systems including photonic crystal fibers
7349589- Photonic crystal fibers and medical systems including photonic crystal fibers
7459155- Treating abdominal pain due to pancreatitis with seaprose
7186843- Aminomethylpyrrolidine derivatives having aromatic substituents
7167622- Photonic crystal fibers and medical systems including photonic crystal fibers
6949662- Cis-substituted aminocyclopropane derivative
6573260- Cycloalkyl-substituted aminomethylpyrrolidine derivatives
6586604- Tricyclic amine derivatives
6656952- Cis-substituted fluoromethylpyrrolidine derivative
6693077- Keratinocyte growth factor-2
6720009- Matrix protein compositions for treating infection
6762181- Aminomethylpyrrolidine derivatives having aromatic substituents
6844010- Therapeutic treatment and prevention of infections with a bioactive materials encapsulated
within a biodegradable-biocompatible polymeric matrix
6902743- Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated
within a biodegradable-bio-compatable polymeric matrix
7563805- Tri-, tetra-substituted-3-aminopyrrolidine derivative
***
Resources from the NCBI used in this document, NCBI's standard disclaimer applies.
Nothing in this document should be used in place of personal medical advice from your own qualified medical
practitioner. See BioPortfolio.com User Agreement
3/4
Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472
Peter Barfoot peter.barfoot@bioportfolio.com
All rights reserved. All other trademarks recognized.
BioPortfolio Limited is registered in England & Wales at Stafford House, 10 Prince of Wales Road,
Dorchester, Dorset, DT1 1PW, UK. No.3312883 VAT No. GB 744 6483 10
Copyright 1997-2010 - BioPortfolio Limited.

4/4